Our final current petition is PE1463, by Lorraine Cleaver, on effective thyroid and adrenal testing, diagnosis and treatment. Members have a note by the clerk and the submissions. I welcome Elaine Smith to the meeting. Members should note that since the committee’s previous consideration of the petition, two of the petitioners—Marian Dyer and Sandra Whyte—have indicated that they no longer wish to be involved in it. I am sure that members would wish to join me in thanking Marian Dyer and Sandra Whyte for their efforts on the petition and wishing them well in the future. I invite Elaine Smith to make a brief contribution, because I know that she has taken a lot of interest in the petition and has a lot of expertise to share.
Official Report · Committee
Current Petitions
Thyroid and Adrenal Testing and Treatment (PE1463)
Speakers
Choose an MSP to read only their contributions- David Stewart Lab 6
- Jackson Carlaw Con 2
- Elaine Smith Lab 1
- Chic Brodie SNP 1
- Angus MacDonald SNP 1
- Anne McTaggart Lab 1
- David Torrance SNP 1
- John Wilson SNP 1
The record
14 contributionsI thank the committee for the time that it has taken so far to look at this petition and for taking it seriously. That gives hope to hundreds, if not thousands, of people in Scotland, particularly, but not only, women.
The last time I was before the committee I was about to go to a conference—I believe that the video is now available; I do not know whether the committee has been able to see it. The conference was excellent and involved patients and people from the profession. I wanted to draw it to your attention, because it was particularly good.
I thank the committee for reading the personal stories that I handed out. Unfortunately, given that a number of the people involved want to remain anonymous, the stories cannot be put in the public domain. People are often frightened that they will be struck off from their GP practices. That fear runs through their stories. There is also the issue of GPs being frightened that they will be struck off for giving patients desiccated thyroid hormone. In relation to that issue, I advise the committee of the sad death of Dr Skinner, whom you will have heard a lot about. Dr Skinner did give patients desiccated thyroid hormone. As you may have read in some of the stories, his death has left some patients desperate to know what will happen to them and how they will stay well in the future if they cannot get the hormone prescribed.
I turn to the Scottish Government letter that the committee received. I will come to the more positive paragraph in a moment, but the second paragraph states that the Scottish Government has no plans to set up a short-life working group because
“there is no evidence base to support the changes being sought by the petition.”
That is a bit dispiriting for the petitioner. Perhaps it is based on not listening to patients and hearing their stories because they are parked on thyroxine. Patients who have an underactive thyroid are put on thyroxine and told, “If you take this pill, you’ll be fine,” so they do not connect the ME that they have been diagnosed with, the hair loss, the weight gain, the heart disease, the fibromyalgia or the depression with their thyroid problem. It seems to me that GPs do not tend to make that connection either.
The guidance on the quality and outcomes framework raises an issue. I understand that points are given for diagnosis, but a lot fewer points are given for diagnosing thyroid problems than for diagnosing depression, although depression can be part of the thyroid problem. That is worrying.
The Government letter refers to there perhaps not being a need for research. We need research to find the evidence—research that is funded not by big pharma but in a different way, so that it does not lead back to thyroxine being the be all and end all for thyroid problems.
11:00
The second part of the Scottish Government’s letter seems more positive, in that the Government says that it will commission a piece of work, although I am not quite clear whether it will be specifically about thyroid conditions or all conditions. Perhaps the committee knows better on that.
The committee has to decide today whether to continue the petition or do something else. That is a matter for the committee, but if I might be so bold as to put my opinion on the record, I think that the committee could keep the petition open to await the outcome of the work that the Government is carrying out and then review the results of that work. Alternatively, members could consider that the issue is so huge—they may have seen that from some of the stories that they have read—that the committee might do its own inquiry, as it has done for other health issues, such as vitamin D deficiency and diabetes, which also tie back to thyroid problems, in one way or another, in quite a lot of cases.
The committee could do its own inquiry, but I think that getting this far in getting attention and action on the issue has been excellent. Patients like me have literally been brought back from the dead—I have no hesitation in saying that. If the issues could be addressed properly and patients could get on to the right treatment, it could save the NHS an absolute fortune in the long run.
The final issue is that there is still only one supplier of T3 in Scotland. I understand that at the moment one batch of T3 has had less potency than other batches, which again is causing people to be ill. The issues are on-going. Personally, I would be grateful if the committee would consider keeping the petition going to await the outcome of the Government’s deliberations as well as looking further into the issues itself.
I thank Elaine Smith for her time and effort, which have been very helpful. Elaine has made a couple of suggestions and there are also suggestions in our briefing paper.
My view is that it is important to keep the petition going. I would like to write to the Scottish Government to seek further details on the timescale for the work that it has committed to undertake in relation to the petition. That does not rule out taking anything further, but I think that we need to get that raw material. In the meantime, if the committee agrees, I see no reason why we should not also write to the Government about the supplier of T3. The Government might feel that the issue is not within its remit, but getting supplies of key medication in Scotland is a sort of devolved issue. It would be interesting to see what the Government’s view is on that.
I agree in general with what you said, convener. Although the T3 issue is clearly very important, I believe that there is a much wider issue in terms of drug issuance and procurement. However, that is for another place, and I support the action that you suggested.
Given the round-table discussion that we had and the very personal testimony that we received and bore witness to, I am rather disappointed and disheartened by the Government’s response. Elaine Smith made a very pertinent point when she said that there is a degree of ambiguity about the piece of work that is to be undertaken, in that it looks as if it might be going to broaden the issue out to be one of generality that is way beyond the particular area that we have been focused on. It would be helpful when you write to the Government about the timelines, convener, to get some idea of the scope of the work and whether it will cover every kind of condition. I want to see progress in relation to the condition on which we have taken a great deal of evidence and have a degree of understanding. I might not necessarily take the same view if conditions were being considered just in the general sense, which might lead to no action being taken at all. It is important that the thing that we have been looking at is not lost in the middle of a discussion about a lot of other things too.
That is a fair point.
For example, the Government refers to
“treatment in areas where the evidence is limited”.
Well, that is homoeopathic medicine. We could be away off down all manner of side routes if we are not careful. It is important that we do not lose sight of the thing that we want to discuss.
Exactly. The work needs to be more specific.
I am keen to get further details from the Scottish Government on the timescale of its work, but we should bear in mind Elaine Smith’s suggestion on the merits of an inquiry and keep that on the table for future consideration.
I will not reiterate other members’ suggestions, but I will highlight Elaine Smith’s concerns about the limitations and production of T3. I am aware that we have approached the cabinet secretary before, but it is extremely important that we find out his views on the matter.
link
I am happy to go along with the recommendations.
Like other members, I agree that we need clarification on paragraph 3 of the Scottish Government’s letter and what it will investigate. Unfortunately Jackson Carlaw is right in saying that a number of conditions could be the subject of such an investigation. The committee has dealt with a number of such issues and Elaine Smith has alluded to some of the conditions that could overlap into a wider debate.
We need the Government to respond more positively on the treatment of patients with the condition. Elaine Smith made an interesting point about T3’s potency and how patients feel that something has changed in the medication that makes it less effective. I am aware that patients with other conditions have made similar points about the prescribed medication not having the same impact. Therefore, when we write to the Scottish Government we should ask it to investigate, if it can, the relative strengths of the medication to ensure that dosage, strength or whatever is consistent.
Given that there is only one supplier of the medication—in effect it has a monopoly on providing the drug—we should tell the Scottish Government about the need to be careful about such monopolies and that we should be seeking the best deal for not only the patients but the NHS.
In summary, we will continue the petition and write to the Scottish Government in the terms identified, including on the issue of the monopoly supplier. We will keep our tactical options, such as whether to hold an inquiry, open until we receive the Government’s response. Do members agree to that course of action?
Members indicated agreement.
I thank Elaine Smith for coming along.
In this meeting
Everything on 18 Feb 2014 →- 09:00 Current Petition Petitions · 80
- 09:45 New Petition Petitions · 46
- 10:30 Current Petitions Petitions · 12
- 10:30 Current Petitions Petitions · 18
- 10:30 Current Petitions Petitions · 10
- 10:30 Current Petitions Petitions · 3
- 10:30 Current Petitions Petitions · 13
- 11:00 Current Petitions Petitions · 14
- 11:00 Tackling Child Sexual Exploitation in Scotland Committee business · 14
The type of each item (debate, statement, questions, members’ business and so on) and the times shown are worked out by this site from headings, the chair’s opening words and the Official Report’s running timestamps. They are not the Parliament’s own classification. Text: the Scottish Parliament Official Report.